Work

γ-Secretase: once and future drug target for Alzheimer’s disease

Year: 2023

Type: editorial

Abstract: 1. Alzheimer’s disease (AD) is a devastating neurodegenerative disorder affecting over 6 million people in the U.S.A. and over 40 million people worldwide [1]. The gradual loss of neurons, particul...

Source: Expert Opinion on Drug Discovery

DOI: 10.1080/17460441.2023.2277350

Author: Michael S. Wolfe

Institution: University of Kansas

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Institute on Aging

Award: Structure and Function of Gamma-Secretase in Familial Alzheimer's Disease

OpenAlex ID: W4388227419

Cites: 20

Cited by: 16

Related to: 10